For the year ending 2025-12-31, APH had $7,813,600K increase in cash & cash equivalents over the period. $4,378,100K in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income | 4,305,300 | 2,441,600 | - | - |
| Net income from continuing operations | - | - | 1,945,500 | 1,916,800 |
| Depreciation and amortization | 922,400 | 572,500 | 406,400 | 392,900 |
| Stock-based compensation expense | 135,400 | 109,500 | 99,000 | 89,500 |
| Deferred income tax benefit | -65,600 | -82,800 | -58,800 | -4,700 |
| Gain on bargain purchase acquisition | 0 | 0 | 5,400 | - |
| Accounts receivable, net | 964,400 | 586,800 | -146,400 | 273,100 |
| Inventories | 487,400 | 200,100 | -71,400 | 278,500 |
| Prepaid expenses and other current assets | 150,700 | 106,800 | 34,100 | -49,700 |
| Accounts payable | 554,100 | 423,100 | -34,600 | 62,500 |
| Accrued income taxes | 276,900 | 3,100 | 7,700 | 77,600 |
| Other accrued liabilities | 739,200 | 257,000 | -7,000 | 168,700 |
| Accrued pension and postretirement benefits | 100 | -2,400 | -300 | -400 |
| Other long-term assets and liabilities | -109,400 | 13,200 | 7,500 | 26,400 |
| Net cash provided by operating activities from continuing operations | - | - | 2,528,700 | 2,174,600 |
| Net cash provided by operating activities from discontinued operations | - | - | 0 | 0 |
| Net cash provided by operating activities | 5,374,700 | 2,814,700 | 2,528,700 | 2,174,600 |
| Capital expenditures | 996,600 | 665,400 | 372,800 | 383,800 |
| Proceeds from disposals of property, plant and equipment | 14,800 | 7,800 | 4,000 | 5,600 |
| Purchases of investments | 309,300 | 26,200 | 305,700 | 309,400 |
| Sales and maturities of investments | 27,600 | 189,700 | 246,300 | 228,200 |
| Acquisitions, net of cash acquired | 3,818,600 | 2,156,400 | 970,400 | 288,200 |
| Other, net | 0 | -1,900 | -4,900 | -16,500 |
| Net cash used in investing activities from continuing operations | - | - | -1,393,700 | -731,100 |
| Net cash provided by investing activities from discontinued operations | - | - | 0 | 0 |
| Net cash used in investing activities | -5,082,100 | -2,648,600 | -1,393,700 | -731,100 |
| Proceeds from issuance of senior notes and other long-term debt | 8,921,700 | 2,991,300 | 354,900 | 5,800 |
| Repayments of senior notes and other long-term debt | 401,700 | 364,400 | 15,700 | 10,300 |
| Borrowings under credit facilities | - | - | - | 0 |
| Repayments under credit facilities | - | - | - | 0 |
| Proceeds from short-term borrowings | - | 0 | 0 | 44,900 |
| Repayments of short-term borrowings | - | 0 | 0 | 44,900 |
| Borrowings (repayments) under commercial paper programs, net | 0 | 0 | -632,600 | -159,300 |
| Payment of costs related to debt financing | 89,100 | 28,400 | 2,300 | 400 |
| Payment of acquisition-related contingent consideration | - | - | - | 0 |
| Payment of deferred purchase price related to acquisitions | 0 | 0 | 1,500 | 0 |
| Purchase of treasury stock | 665,200 | 689,300 | 585,100 | 730,500 |
| Proceeds from exercise of stock options | 553,000 | 447,400 | 394,500 | 185,300 |
| Distributions to and purchases of noncontrolling interests | 5,800 | 33,000 | 24,000 | 9,900 |
| Dividend payments | 802,200 | 595,100 | 500,600 | 477,400 |
| Transfers to discontinued operations | - | - | 0 | 0 |
| Net cash used in financing activities from continuing operations | - | - | -1,012,400 | -1,196,700 |
| Treasury lock settlement | 88,000 | - | - | - |
| Net cash used in financing activities from discontinued operations | - | - | 0 | 0 |
| Other, net | 500 | 1,400 | - | - |
| Net cash provided by (used in) financing activities | 7,423,200 | 1,729,900 | -1,012,400 | -1,196,700 |
| Effect of exchange rate changes on cash and cash equivalents | 97,800 | -54,000 | -20,700 | -70,800 |
| Net increase in cash and cash equivalents | 7,813,600 | 1,842,000 | 101,900 | 176,000 |
| Cash and cash equivalents at beginning of period | 3,317,000 | 1,475,000 | 1,373,100 | 1,197,100 |
| Cash and cash equivalents at end of period | 11,130,600 | 3,317,000 | 1,475,000 | 1,373,100 |
AMPHENOL CORP DE (APH)
AMPHENOL CORP DE (APH)